Cohort Study
Impact of nodal involvement on survival outcomes in chondrosarcoma: retrospective cohort analysis of Surveillance, Epidemiology, and End Results (SEER) database (2004–2015)
Authors:
Lee D. Cranmer ,
Medical Oncology Division, University of Washington, 825 Eastlake Ave. East, CE2-128, Seattle, WA 98109; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, US
About Lee D.
MD, PhD, FACP
Bonny Chau,
Medical Oncology Division, University of Washington, Seattle, WA, US
About Bonny
MPH
Matthew J. Thompson,
Department of Orthopedics and Sports Medicine, University of Washington, Seattle, WA, US
About Matthew J.
MD
Elizabeth T. Loggers,
Medical Oncology Division, University of Washington, Seattle, WA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, US
About Elizabeth T.
MD, PhD
Seth M. Pollack,
Medical Oncology Division, University of Washington, Seattle, WA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, US
About Seth M.
MD
Michael J. Wagner,
Medical Oncology Division, University of Washington, Seattle, WA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, US
About Michael J.
MD
Teresa S. Kim,
Department of Surgery, University of Washington, Seattle, WA, US
About Teresa S.
MD
Edward Y. Kim,
Department of Radiation Oncology, University of Washington, Seattle, WA, US
About Edward Y.
MD
Gabrielle M. Kane,
Department of Radiation Oncology, University of Washington, Seattle, WA, US
About Gabrielle M.
MB, EdD, FRCPC
Gabriel J. Pavey
Department of Orthopedics and Sports Medicine, University of Washington, Seattle, WA, US
About Gabriel J.
MD
Abstract
Objectives: Factors associated with nodal involvement in chondrosarcoma and outcomes based on treatment modality were analyzed using the Surveillance, Epidemiology, and End Results (SEER) database.
Methods: Chondrosarcomas involving axial and appendicular parts of the body diagnosed from 2004 to 2015 were identified in SEER. Clinical, pathologic, and treatment parameters were compared with respect to nodal status at initial diagnosis by Fisher’s exact or Student’s t-test. Disease-specific survival (DSS) and overall survival (OS) were evaluated by Kaplan-Meier analyses, and by Cox regression models.
Results: Synchronous regional nodal metastases were present in 1.3% of chondrosarcoma patients. Lymph node involvement was associated with primary tumor location in extraskeletal tissue and the pelvis, and with distant metastasis and larger primary tumor size at diagnosis. Patients with nodal involvement had 5-year DSS of 48% [95% confidence interval (CI): 28%–65%], versus 82% (95%CI: 80%–84%) for those without (log-rank P<0.001). 5-yearOSwith and without nodal involvement were 38% (95% CI: 21%–55%) and 73% (95% CI: 71%–75%), respectively (log-rank P<0.001). Surgical excision of nodes was associated with improved DSS and OS. Radiation and chemotherapy were not associated with improved DSS/OS.
Conclusions: The nodal disease is uncommon at presentation in chondrosarcoma. Greater clinical vigilance for regional nodal metastases may be warranted for those with specific risk factors, including extraskeletal or pelvic primary sites, myxoid, mesenchymal, or dedifferentiated histologies, and large size. Surgical excision of regional nodes is associated with improvedDSS/OS. This analysis suggests a therapeutic effect of surgical treatment, rather than selection for favorable underlying biological factors.
How to Cite:
Cranmer LD, Chau B, Thompson MJ, Loggers ET, Pollack SM, Wagner MJ, et al.. Impact of nodal involvement on survival outcomes in chondrosarcoma: retrospective cohort analysis of Surveillance, Epidemiology, and End Results (SEER) database (2004–2015). International Journal of Surgery: Oncology. 2020;5(4):e91. DOI: http://doi.org/10.1097/IJ9.0000000000000091
Published on
26 Jun 2020.
Peer Reviewed
Downloads
